A retrospective analysis of the efficacy between dasatinib and nilotinib for chronic myeloid leukemia

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: WU, Chia-Hsuan (Chi-Mei Medical Center, Pharmacy, Tainan, China Taiwan)
  • Co-author(s): Yu-Jou Lin Department of Pharmacy, Chi-Mei Medical Center, Tainan City, Taiwan, Province of China
    Chia-Hsuan Wu
    Hui-Chen Su
  • Abstract:


    This is a retrospective study. Patients administered dasatinib or nilotinib from 2012 to 2016 in a medical center in southern Taiwan are included. We analyze the hematological response, molecular response and side effects between patients with dasatinib and nilotinib.


    There were 10 patients included for analysis. 6 patients..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login